Our mission is to give hope to patients of 'undruggable' neurodegenerative diseases and cancers.
We searched where none had gone before to find the missing data to unblock drug design for intrinsically disordered proteins.
Find the missing data for drug discovery.
Analyse what microgravity reveals.
Work with our MB-X automated platform to run reveal protein states obscured at 1g.
Model & design with SpaceFold.
Licence SpaceFold to supercharge foundational models and accelerate discovery.
Around half of our proteins are IDPs with no fixed shape for drugs to target. They are kryptonite to AI.
On Earth, gravity-driven sedimentation and convection blur their behaviour. In orbit, those forces disappear.
No sedimentation
Protein assemblies remain suspended long enough to observe their native behaviour.
No convection
Removing gravity-driven flow reveals molecular interactions without turbulence.
Diffusion-limited
A quieter environment lets weak molecular signals emerge with unusual clarity.
MB-X1 reached orbit.
Our Mission 1 payload flew on SpaceX Transporter-17 in July 2026 (image credit: SpaceX).
Selected for SPRIN-D Orbital Bioworks Challenge
Stage 1 funding secured from Germany’s Federal Agency for Breakthrough Innovation challenge for biotechnology in space.
01
Mission 1: complete Q3 2026
02
M2: Flight 1 booked Q1 2027
03
M2: Flight 2 Q3 2027
04
M2: Return capsule/crewed station
IDP TARGETS · CNS AND ONCOLOGY
Build with us.
We collaborate with researchers, drug developers, builders and investors working at the edges of biology, AI, and space.